Search for: "Pfizer Inc. v. United States"
Results 21 - 40
of 228
Sorted by Relevance
|
Sort by Date
27 Dec 2012, 3:47 pm
Pfizer, Inc., 825 F. [read post]
28 Mar 2014, 5:33 pm
MagSil Corp. v. [read post]
22 Feb 2010, 6:07 am
In Goodridge v Pfizer Canada Inc., 2010 ONSC 1095 (Feb. 18, 2010), the plaintiffs claimed injuries from off-label use of Neurontin and its generic version. [read post]
8 Oct 2012, 10:34 am
Pfizer Inc. [read post]
30 May 2010, 3:55 pm
Kellogg, Brown & Root Service, Inc., and Pfizer, Inc. v. [read post]
20 Sep 2016, 7:43 pm
Pfizer, Inc., C.A. [read post]
27 Aug 2010, 3:42 pm
Pfizer, Inc., No. [read post]
24 May 2011, 6:12 pm
Pfizer, Inc., 233 P.3d 1066 (Cal. 2010), make clear that section 17204 only requires that a party allege an injury in fact and that the injury was caused by the defendant. [read post]
3 Feb 2009, 4:23 am
Pfizer, Inc., Docket Nos. 05-4863-cv (L), 05-6768-cv (CON), slip op. (2d Cir. [read post]
17 Feb 2009, 6:53 am
Pension Fund v. [read post]
24 May 2018, 12:27 am
Cir. 2007) (quoting United States v. [read post]
20 Mar 2009, 2:05 am
United States, 880 F.2d 84, 86-87 (8th Cir. 1989).Kansas: Savina v. [read post]
10 Jul 2007, 4:58 am
Last Thursday however, the Third Department affirmed a dismissal of the class action suit finding that the plaintiff failed to state a cause of action in Baron v Pfizer, Inc., 2007 NY Slip Op 05813. [read post]
8 Dec 2017, 3:00 am
Pfizer stated that Corber v. [read post]
2 Nov 2009, 7:20 am
Opinion below (6th Circuit) Petition for certiorari Brief in opposition Petitioner's reply Amicus brief for 29 states The Court has invited the Solicitor General to submit briefs in the following cases: Docket: 09-34 Title: Pfizer Inc. v. [read post]
14 Mar 2023, 11:48 pm
Pfizer, Inc., 2009 WL 3320272, at *2 (N.D. [read post]
25 Jul 2012, 2:21 pm
Pfizer, Inc., 2012 WL 2970627 (D. [read post]
31 Jul 2017, 7:00 am
United States, 292 F. [read post]
3 Mar 2012, 5:36 pm
United States, 597 F. [read post]
30 Mar 2007, 9:48 am
After Teva Pharmaceuticals appealed the dismissal of its declaratory judgment action in District Court, the United States Court of Appeals for the Federal Circuit has taken a fresh new look at things in light of the Supreme Court's decision in MedImmune, Inc. v. [read post]
